Brequinar Combined With Dipyridamole in Patients With Mild to Moderate COVID-19

NCT05166876 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

26

Enrollment

INDUSTRY

Sponsor class

Stopped Low prevalence of COVID-19 in India led to lack of eligible subjects.

Conditions

COVID-19

Interventions

DRUG: Brequinar Sodium
DRUG: Dipyridamole 75 MG
DRUG: Placebo

Sponsor

Clear Creek Bio, Inc.